GlassScriptPhysician profile
Robert A Muggia
NPI 1982662813
$1,416.29
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $838 · 2020: $259 · 2021: $197 · 2022: $101 · 2023: $20.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $20.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $20.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $439.65 | 2019-2022 | |
| Gilead Sciences, INC. | $164.54 | 2019 | |
| Janssen Biotech, INC. | $133.35 | 2019-2020 | |
| Cook Medical LLC | $117.34 | 2021 | |
| Shionogi INC | $98.60 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $88.75 | 2019-2021 | |
| Pfizer INC. | $64.53 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $64.28 | 2019-2020 | |
| Allergan, INC. | $52.98 | 2019-2020 | |
| Organon LLC | $40.43 | 2021 | |
| Ucb, INC. | $35.49 | 2019 | |
| Shire North American Group INC | $31.65 | 2019 | |
| Celgene Corporation | $20.99 | 2023 | Zeposia |
| Ironwood Pharmaceuticals, INC | $20.91 | 2019 | |
| Alfasigma USA, INC. | $18.03 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $13.43 | 2019 | |
| Endo Pharmaceuticals INC. | $11.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Muggia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.